Long-term exposure to the pesticide chlorpyrifos, widely used on US farms, has been linked to a more than 2.5-fold increase ...
Now in its ninth year of service, Rock Steady Boxing Southern Tier NY provides programs to over 100 people with Parkinson’s ...
Biotechs with drugs on the market were eager to share their fourth quarter revenue with investors as the J.P. Morgan 2026 Healthcare Conference kicked off today with some even brave enough to give ...
Iowa Sen. Art Staed, D-Cedar Rapids, will propose legislation banning a Chinese-manufactured pesticide, saying he believes it ...
The U.S. Environmental Protection Agency will be looking at the safety of paraquat, a toxic weed killer that lawsuits have ...
Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...
NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...
Summit Therapeutics Inc. (SMMT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Summit Therapeutics Inc. ( SMMT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST ...
Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...
Watch for early signs of Parkinson's disease, like stiffness and slower movements. Early detection is key to better ...
Clinical Trials Arena on MSN
NRG doses first participants in Phase I trial for ALS and Parkinson’s
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results